Biotech · Private company · Lancaster, CA, US
Reparris, Inc.
Track this companyFree. Adds Reparris, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards1
- Pre-clinical development of a novel allosteric inhibitor of SRC kinase for spontaneous multi-joint osteoarthritis (OA) and OA-associated chronic painFiscal year 2026 · $301.6KNIH RePORTER 1R44AR086030-01A1 · fetched Nov 12, 2026